Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Hldgs LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 202.50p 195.00p 210.00p 202.50p 200.00p 200.00p 0.00 08:00:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 38.3 -37.0 -109.7 - 59.57

Immunodiagnostic Systems Share Discussion Threads

Showing 851 to 873 of 875 messages
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older
DateSubjectAuthorDiscuss
23/10/2016
23:44
The chart says it all This stock is in trouble free stock charts from uk.advfn.com Recent profit warning suggests blue line to be tested once more
buywell3
25/8/2016
07:21
Any news that I'm unaware of?
junior21
09/6/2016
08:01
Larger partner could strip out opex, and run the existing business off for cash. Cash would also significantly reduce implied ev. Will be on the radar for the big cash rich players. Could be a sizeable premium.
wigwammer
09/6/2016
07:33
value trap. avoid
r ball
09/6/2016
07:31
It just seems to get worse and worse. This will become an interesting recovery play in time.If/when it gets to 80p I might buy a few.
longshanks
09/6/2016
07:28
Management have been asleep at the wheel.Circa 85p cash and high gross margin.Takeout candidate.
wigwammer
06/5/2016
09:03
£42m market cap, £26m cash, £35m net tangible equity, and a (albeit declining) business making £39m turnover at 60%+ gross margins.Quite interesting.
wigwammer
29/6/2015
06:39
The directors office revolving door continues
spacecake
23/6/2015
07:47
broker comment Immunodiagnostic Systems Holdings (IDH LN) Sell Healthcare Full Year Results Prelims in line – outlook remains challenging FY15 was a difficult year and FY16 is unlikely to be any better. Our forecasts and Target Price remain under review, and we see little prospect of a rapid turnaround in the group’s fortunes. We retain our Sell recommendation.
albanyvillas
29/5/2015
16:13
Hi Pug. Don't hold myself but have an interest via ODX (whom are developing a product in collaboration with IDH). They do seem to be struggling with net placement of machines. Not sure as to why they are getting returned: competition or business disappearing? Doesn't look like the geographic expansion plans are going well either.
longshanks
29/5/2015
07:35
Looks like significant warning on both sales and profits to me (imo etc) Looks as though both singer and Cnaccord were right in call this a sell in March and April respectively I suspect we may see further broker downgrades after today's statement. BIG QUESTION: Why are sales down - Competitive activity ? Better competitive products ? Thoughts - Knowledge ? Declaration - Do not hold but been on watch list.
pugugly
29/5/2015
06:48
Is this a profit warning with sales below epectations?
dlku
17/3/2014
10:49
modestly priced for such a great growth stock in recent times. statement looked alright.
undervaluedassets
14/3/2014
12:30
......or it may be the China angle?
123prezzie
13/3/2014
09:06
I hold quite a few bought in stages from 245p onwards. The thing that intrigues me most is the China angle and also the net cash pile which keeps on growing. At some stage, I hope, we should be rewarded with a special dividend. I think the current drop over successive days may be a tree shake before results.
bigboyo
12/3/2014
21:57
Your comments noted, UVA, thanks. I prefer to sit tight unless something is wrong. Also hold it's cousin,ODX, which is also doing quite well for me.
123prezzie
12/3/2014
15:22
There is nothing wrong here. Little pull back on no news. valuation looks undemanding for this kind of a stock.
undervaluedassets
11/3/2014
10:08
Can anyone comment in the fall in the share price which seems to correlate with the departure of Dr Wittek (non-exec) from the Board? This is a negelected thread considering the useful increase in share price. I came in at 290 after the big drop - should I be exiting?
123prezzie
17/6/2013
17:36
Investec has downgraded its recommendation on medical diagnostic product manufacturer Immunodiagnostic Systems [LON:IDH] to 'hold' from 'buy' after the company published an in-line set of preliminary results, believing the shares will pause for breath after the recent strong run. The shares have increased in value by 40 per cent since the beginning of the year. The City broker has increased its price target to 460 pence per share (up from 360 pence). Separately, N+1 Singer has reaffirmed its 'buy' rating and 395 pence price target, while Canaccord Genuity has stuck with its 'hold' call leaving its price target unchanged at 404 pence per share. At 10:09am: Immunodiagnostic Systems share price was unchanged at 447.5 pence. (Courtesy of brokerforecasts.com)
major clanger
12/6/2013
14:43
IDH d/g by Canaccord: www.brokerforecasts.com/news/article/articleId/4612799
major clanger
10/4/2013
12:29
There's an interesting post on IDH's trading statement by paulypilot at - http://www.-.co.uk/content/small-cap-report-10-apr-demg-prz-idh-ver-72345/ "It's been a very successful company in the past, so if you think management can turn it around, then the shares could be cheap. If you think more decline is likely, then they may not be cheap. I think it looks interesting, and will try to dig deeper when time permits."
stockhound
01/2/2013
10:51
seems to be a buyer happy to take stock around the 306/307 level
sportbilly1976
10/1/2013
16:11
Interesting....will watch closely to see how it develops
sportbilly1976
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20161207 16:20:39